Big pharma scores first victory in IPR battle with Bass and Spangenberg, but the war is far from over

As anyone keeping score will know it’s currently big pharma 2 – Kyle Bass/Erich Spangenberg 0. The decision earlier this week by the Patent Trial and Appeal Board (PTAB) not to institute inter partes reviews of two patents owned by pharmaceutical…

Get unlimited access to all IAM content